Your browser doesn't support javascript.
loading
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Fu, Qihan; Chen, Yiwen; Huang, Dabing; Guo, Chengxiang; Zhang, Xiaochen; Xiao, Wenbo; Xue, Xing; Zhang, Qi; Li, Xiang; Gao, Shunliang; Que, Risheng; Shen, Yan; Wu, Jian; Zhang, Min; Bai, Xueli; Liang, Tingbo.
Afiliación
  • Fu Q; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Chen Y; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Huang D; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Guo C; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Zhang X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Xiao W; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Xue X; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhang Q; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Li X; Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Gao S; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Que R; Department of Radiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Shen Y; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wu J; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Zhang M; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Bai X; The Key Laboratory of Pancreatic Diseases of Zhejiang Province, Hangzhou, China.
  • Liang T; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ann Surg Oncol ; 30(8): 5071-5080, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37052821
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders / 6_pancreatic_cancer Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China